REVELATION BIOSCIENCES, INC. Proceeds from Previous Acquisition
REVELATION BIOSCIENCES, INC. (REVB) had Proceeds from Previous Acquisition of $11.90 million as of 2022-01-10, per its 10-K/A filed 2024-09-23.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromPreviousAcquisition · last filed 2024-09-23
- 2022-01-10: Proceeds from Previous Acquisition $11.90M.
| Period end | Proceeds from Previous Acquisition |
|---|---|
| 2022-01-10 | $11.90M 10-K/A · filed 2024-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |